Encyclopedia of Metalloproteins

2013 Edition
| Editors: Robert H. Kretsinger, Vladimir N. Uversky, Eugene A. Permyakov

Calsequestrin

Reference work entry
DOI: https://doi.org/10.1007/978-1-4614-1533-6_38

Synonyms

 CASQ;  CSQ

Definition

Calsequestrin, a ~40 kD protein, binds Ca2+ with high capacity (40–50 mol Ca2+ mol−1 calsequestrin) but with moderate affinity (Kd = 1 mM) over a Ca2+ concentration range between 0.01 and 1 M and releases it with a high off-rate (106 s−1). A high concentration of calsequestrin (up to 100 mg mL−1) is present in the lumen of the junctional terminal cisternae of the sarcoplasmic reticulum (SR) (MacLennan and Chen 2009; Royer and Ríos 2009). In humans, there are two major isoforms; the skeletal muscle calsequestrin (Casq1) and the cardiac muscle calsequestrin (Casq2). They are encoded by casq1 and casq2 located on chromosomes 1q21 and 1p13.3-p11 and are the only isoforms in fast-twitch skeletal muscle and cardiac muscle, respectively. In slow-twitch skeletal muscle, Casq1 is the major isoform with Casq2 as minor. In general, the Ca2+-binding capacity of Casq2 is higher than that of Casq1. Isoforms of calsequestrin are also present in the endoplasmic...

This is a preview of subscription content, log in to check access

References

  1. Dulhunty A, Wei L, Beard N (2009) Junctin - the quiet achiever. J Physiol 587:3135–3137 (Review)CrossRefPubMedGoogle Scholar
  2. Györke S, Stevens S, Terentyev D (2009) Cardiac calsequestrin: quest inside the SR. J Physiol 587:3091–3094 (Review)CrossRefPubMedGoogle Scholar
  3. Kang C, Nissen M, Sachez E, Milting H (2010) Potential adverse interaction of human cardiac calsequestrin. Eur J Pharmacol 646:12–21CrossRefPubMedGoogle Scholar
  4. Kim E, Tam M, Siems WF, Kang C (2005) Effects of drugs with muscle-related side effects and affinity for calsequestrin on the calcium regulatory function of sarcoplasmic reticulum microsomes. Mol Pharmacol 68:1708–1715PubMedGoogle Scholar
  5. Kim E, Youn B, Kemper L, Campbell C, Milting H, Varsanyi M, Kang C (2007) Biochemical analysis of human cardiac calsequestrin and its deleterious mutants. J Mol Biol 373:1047–1057CrossRefPubMedGoogle Scholar
  6. Knollmann B (2009) New roles of calsequestrin and triadin in cardiac muscle. J Physiol 587:3081–3087CrossRefPubMedGoogle Scholar
  7. MacLennan D, Chen S (2009) Store overload-induced Ca2+ release as a triggering mechanism for CPVT and MH episodes caused by mutations in RYR and CASQ genes. J Physiol 587:3113–3115 (Review)CrossRefPubMedGoogle Scholar
  8. McFarland T, Milstein M, Cala S (2010) Rough endoplasmic reticulum to junctional sarcoplasmic reticulum trafficking of calsequestrin in adult cardiomyocytes. J Mol Cell Cardiol 49:556–564CrossRefPubMedGoogle Scholar
  9. Milstein M, Houle T, Cala S (2009) Calsequestrin isoforms localize to different ER subcompartments: evidence for polymer and heteropolymer-dependent localization. Exp Cell Res 315:523–534CrossRefPubMedGoogle Scholar
  10. Park H, Wu A, Dunker A, Kang C (2003) Polymerization of Calsequestrin: Implications for Ca2+ Regulation. J Biol Chem 278:16176–16182CrossRefPubMedGoogle Scholar
  11. Park H, Park I-Y, Kim E, Youn B, Fields K, Dunker A, Kang C (2004) Comparing skeletal and cardiac calsequestrin structures and their calcium binding: a proposed mechanism for coupled calcium binding and protein polymerization. J Biol Chem 279:18026–18033CrossRefPubMedGoogle Scholar
  12. Park I, Kim E, Park H, Fields K, Dunker K, Kang C (2005) Interaction between cardiac calsequestrin and drugs with known cardiotoxicity; A potential source for the cardiac side effects. J Mol Pharmacol 67:95–105CrossRefGoogle Scholar
  13. Royer L, Ríos E (2009) Deconstructing calsequestrin. Complex buffering in the calcium store of skeletal muscle. J Physiol 587:3101–3111CrossRefPubMedGoogle Scholar
  14. Sanchez E, Munske G, Criswell A, Milting H, Dunker A, Kang C (2011) Phosphorylation of human calsequestrin: implications for calcium regulation. Mol Cell Biochem 353:195–204CrossRefPubMedGoogle Scholar
  15. Sanchez E, Lewis K, Danna B, Kang C (2012) High-capacity Ca2+-binding of human skeletal calsequestrin. J Biol Chem 287:11592–11601CrossRefPubMedGoogle Scholar
  16. Sanchez E, Lewis K, Munske G, Nissen M, Kang C (2012) Glycosylation of skeletal calsequestrin, implications for its function. J Biol Chem 287:3042–3050CrossRefPubMedGoogle Scholar
  17. Wang S, Trumble W, Liao H, Wesson C, Dunker A, Kang C (1998) Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum. Nat Struct Biol 5:476–483CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Washington State UniversityPullmanUSA